source
- Iowa audit finds PBM kept over $100 million by inflating Medicaid drug costsA recent audit of Iowa's Medicaid program uncovered that a major pharmacy benefit manager used complex claim handling methods that led to higher costs for the state. The review of records from 201…
- Kyverna Therapeutics aims to file first CAR-T cell therapy for autoimmune diseaseKyverna Therapeutics is preparing what could become the first regulatory filing for a CAR-T cell therapy targeting an autoimmune condition. The company has been developing its miv-cel construct in…